It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

Kennedy's HHS appointment, Trump's DEA pick, new fast-track meds, and global cannabis trends—this week reshapes the future of ...

In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. (NASDAQ:EPIX) between December 12, ...

No. 3 / 2025Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus medication litifilimab. In return, Royalty Pharma will receive undisclosed ...

Budget 2025: Pharma stocks experienced a mixed trading ... This initiative not only stands to improve healthcare access but also has the potential to significantly benefit the Indian economy.

To further support pharmaceutical manufacturing ... They believe this step will significantly improve access to cancer care, particularly for underprivileged patients, while reducing the burden ...

Strides Pharma Science announced the change in designation of Arun Kumar (DIN: 00084845) from Executive Chairperson to Non-Executive Chairperson of the Company effective 05 April 2025. Arun Kumar, ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.

As the pharmaceutical landscape evolves, ensuring market access should remain a top priority for industry stakeholders. As we look ahead to a year of expected advancements, several key trends will ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...